S. Gail Eckhardt

Also affiliated with Baylor College of Medicine, The University of Texas at Austin

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer

(2023)10.1158/0008-5472.c.6513646.v1

Top 100%

0DataRank

Top 100%0 citations

Yongsheng Li, Sairahul R. Pentaparthi, Daniel J. McGrail, Raymond Zou, Li Guo +22 more

Papers

Driven by 21 papers — median percentile 0. Top paper: “Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data”.

Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data

Nature Computational Science(2024)10.1038/s43588-024-00597-5

N/A

0.617DataRank · unranked

17 citations

Anna Capasso, S. Gail Eckhardt, Uma Giri, Alexander Somma, Todd M. Pitts +9 more

e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks

Nucleic Acids Research(2020)10.1093/nar/gkaa1015

N/A

0DataRank · unranked

18 citations

Brandon Burgman, Ishaani S Khatri, Sairahul R. Pentaparthi, Zhe Su, Daniel J. McGrail +6 more

RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer

BMC Cancer(2020)10.1186/s12885-020-07500-1

N/A

0DataRank · unranked

30 citations

Julie Lang, Anna Capasso, Deog Joong Kim, Ely Benaim, Young Bok Lee +10 more

Results from the safety lead-in for a phase II study of pembrolizumab in combination with binimetinib and bevacizumab in patients with refractory metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4031

N/A

0DataRank · unranked

8 citations

S. Lindsey Davis, Stephen Leong, Alexis D. Leal, Patrick J. Blatchford, Gurprataap Singh Sandhu +15 more

Comprehensive and Integrated Genomic Characterization of Human Immunome in Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.02.128884

N/A

0DataRank · unranked

0 citations

Todd Triplett, Brandon Burgman, Ming Sun, Daniel J. McGrail, Dan Qi +10 more

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

UNC Libraries(2020)10.17615/7cf0-0a25

N/A

0DataRank · unranked

0 citations

John J. Tentler, H. Shelton Earp, Stephen V. Frye, Amanda Winges, Weihe Zhang +20 more

Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes

Frontiers in Immunology(2021)10.3389/fimmu.2021.607282

N/A

0DataRank · unranked

50 citations

Anna Capasso, Matthew S. Lewis, Stacey M. Bagby, Sarah J. Hartman, Jeremy Shulman +26 more

Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0455

N/A

0DataRank · unranked

25 citations

Todd M. Pitts, Dana Ungermannova, Christopher G. Nasveschuk, Gan Zhang, Andrew J. Phillips +15 more

A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1799

N/A

0DataRank · unranked

6 citations

Gary M. Clark, Charles A. Coltman, Mary L. Disis, S. Gail Eckhardt, Lee M. Ellis +21 more

Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models

Frontiers in Oncology(2022)10.3389/fonc.2022.877635

N/A

0DataRank · unranked

16 citations

Alexis D. Leal, Juan A. Marín‐Jiménez, Sarah J. Hartman, Jeremy Shulman, Natalie M. Navarro +14 more

A phase II study of pembrolizumab, binimetinib, and bevacizumab in patients with microsatellite-stable, refractory, metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.118

N/A

0DataRank · unranked

8 citations

Patrick J. Blatchford, Robert W. Lentz, S. Lindsey Davis, Sunnie S. Kim, Alexis D. Leal +9 more

Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.20.524974

N/A

0DataRank · unranked

2 citations

Anna Capasso, S. Gail Eckhardt, Uma Giri, Alexander Somma, Todd M. Pitts +9 more

Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer

(2023)10.1158/0008-5472.c.6513646.v1

Top 100%

0DataRank

Top 100%0 citations

Yongsheng Li, Sairahul R. Pentaparthi, Daniel J. McGrail, Raymond Zou, Li Guo +22 more

Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer

(2023)10.1158/0008-5472.c.6513646

Top 100%

0DataRank

Top 100%0 citations

Yongsheng Li, Sairahul R. Pentaparthi, Daniel J. McGrail, Raymond Zou, Li Guo +22 more

Data from Integrated Genomic Characterization of the Human Immunome in Cancer

(2023)10.1158/0008-5472.c.6512134.v1

N/A

0DataRank · unranked

0 citations

Brandon Burgman, Daniel J. McGrail, Ming Sun, Dan Qi, Sachet A. Shukla +10 more

Data from Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors

(2023)10.1158/1078-0432.c.6520385.v1

N/A

0DataRank · unranked

0 citations

David S. Boss, D. Ross Camidge, Carolyn D. Britten, Jeffrey A. Engelman, Edward B. Garon +9 more

Data from Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors

(2023)10.1158/1078-0432.c.6520385

N/A

0DataRank · unranked

0 citations

David S. Boss, D. Ross Camidge, Carolyn D. Britten, Jeffrey A. Engelman, Edward B. Garon +9 more

Data from Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors

(2023)10.1158/1535-7163.c.6543273.v1

N/A

0DataRank · unranked

0 citations

Todd M. Pitts, Dana Ungermannova, Christopher G. Nasveschuk, Gan Zhang, Andrew J. K. Phillips +15 more

Data from Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors

(2023)10.1158/1535-7163.c.6543273

N/A

0DataRank · unranked

0 citations

Todd M. Pitts, Dana Ungermannova, Christopher G. Nasveschuk, Gan Zhang, Andrew J. K. Phillips +15 more

Integrated Genomic Characterization of the Human Immunome in Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-0384

N/A

0DataRank · unranked

32 citations

Brandon Burgman, Daniel J. McGrail, Ming Sun, Dan Qi, Sachet A. Shukla +10 more

A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0090

N/A

0DataRank · unranked

9 citations

Tyler J. Friedrich, Patrick J. Blatchford, Kimberly R. Jordan, Todd M. Pitts, Hannah R. Robinson +13 more

S. Gail Eckhardt

Indexed papers

Top data-sharing exemplar

Papers